Specialty pharmaceuticals is a unique niche in the pharma sector. Where companies like Eli Lilly pour billions into developing a drug candidate from scratch with the very real possibility…
MDP.T
Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF), a leading specialty pharmaceutical company, has been making waves with record annual revenues, a new credit agreement, and the acquisition of the Canadian…
Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF), a leading specialty pharmaceutical company, has been making waves with record annual revenues, a new credit agreement, and the acquisition of the Canadian…
Specialty pharmaceuticals is a unique niche in the pharma sector. Where companies like Eli Lilly pour billions into developing a drug candidate from scratch with the very real possibility…
Medexus Pharmaceuticals (MDP.TO), a specialty pharma company, today announced preliminary revenue estimates for Q4 and the full fiscal year ended March 31st 2023 as well as a business update….
Medexus Pharmaceuticals (MDP.TO), a leading specialty pharma company, today announced that it has secured the Canadian rights to commercialize terbinafine hydrochloride nail lacquer supplied by Polichem, an Almirall group…
10 March 2023
Medexus Pharmaceuticals (MDP.T) deals with its debentures
Chris Parry- MDP.T
Shareholders and the investment community became concerned that Medexus Pharmaceuticals (MDP.T) would not be able to deal with the imminent expiry of convertible debentures the company had issued early…
Specialty pharmaceuticals is a unique niche in the pharma sector. Where companies like Eli Lilly pour billions into developing a drug candidate from scratch with the very real possibility…
Medexus CEO (MDP.T) on creating Canada’s specialty pharma success story Specialty pharmaceuticals is a unique niche in the pharma sector. Where companies like Eli Lilly pour billions into developing…
Buzz on the discussion boards when it comes to Medexus and a series of debentures expiring next year, has not been positive, but is there any basis for real…